Last update 11 Oct 2025

BRL-302

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms
BRL302
Target
BCMA
Action
modulators
Mechanism
BCMA modulators(B-cell maturation protein modulators)
Therapeutic Areas
NeoplasmsImmune System DiseasesInfectious Diseases+ [4]
Active Indication
Metastatic castration-resistant prostate cancerAQP4-IgG positive Neuromyelitis optica spectrum disorderAutoimmune Diseases
Inactive Indication-
Originator Organization
BRL Medicine IncBRL Medicine Inc
Active Organization
BRL Medicine IncBRL Medicine Inc
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with BRL-302
NCT06895811
/ RecruitingPhase 1IIT
The Safety and Efficacy Evaluation of Universal PSMA Chimeric Antigen Receptor T Cells in the Treatment of Refractory Castration Resistant Prostate Cancer
NCT06633042
/ Not yet recruitingPhase 1
The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disease
100 Clinical Results associated with BRL-302
Login to view more data
100 Translational Medicine associated with BRL-302
Login to view more data
100 Patents (Medical) associated with BRL-302
Login to view more data
100 Deals associated with BRL-302
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic castration-resistant prostate cancerPhase 1
China
BRL Medicine IncBRL Medicine Inc
27 Mar 2025
AQP4-IgG positive Neuromyelitis optica spectrum disorderPhase 1-
BRL Medicine IncBRL Medicine Inc
25 Nov 2024
Autoimmune DiseasesClinical
China
BRL Medicine IncBRL Medicine Inc
27 Feb 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free